Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 45 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Evaluate the Safety of the Goldilocks Procedure with Implant-Based Reconstruction

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. The Use of Topical Tranexamic Acid in Implant-Based Breast Reconstruction with Acellular Dermal Matrix

    Rochester, MN

  3. Real-time Disease Monitoring of Metastatic Breast Cancer to Optimize Treatment

    Scottsdale/Phoenix, AZ

  4. A Study to Compare the Cosmetic Outcome of Superomedial and Inferior Pedicle Breast Reduction

    Rochester, MN

  5. Study of Breast Cancer Risk Assessment in Female Patients with Benign Breast Disease

    Rochester, MN, Jacksonville, FL

  6. A Study to Evaluate the Development of Patient Derived Xenografts in Patients With Breast Cancer

    Rochester, MN

  7. A Study to Develop a Biorepository of Blood Samples from Cancer Patients Participating in the Gemini (IRB 19-006717) Protocol

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  8. Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer, the ENHANCE Study

    Rochester, MN

  9. A Study to Collect Clinical Data, Blood Samples, and Tissue Specimens from Patients with Metastatic Breast Cancer

    Rochester, MN

  10. A Study to Evaluate Screening Contrast Enhanced Digital Mammogram (CEDM) in Study Participants at Intermediate Breast Cancer Risk and Polygenic Risk Score (PRS) Results

    Rochester, MN

.

Mayo Clinic Footer